Sourasky Medical Center ( Site 1603)

Tel Aviv 6423906

1 studies enrolling now · 2 studies all time

What they study most

Malignant Neoplasms, Triple Negative Breast Neoplasms, Von Hippel-Lindau Disease

Studies at this site

• Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) — Recruiting now
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) — Completed